In conjunction with farnesyltransferase inhibitor inhibitor HMG CoA reductase inhibitor for treating cancer

• 1. 法尼基转移酶抑制剂与HMG CoA还原酶抑制剂结合用于治疗癌症 [P] . 中国专利： CN1259868A . 2000-07-12
• 2. 蛋白质法尼基转移酶与HMG CoA还原酶抑制剂的组合及其治疗癌症的用途 [P] . 中国专利： CN1171874C . 2004.10.20
• 3. Farnesyltransferase inhibitors in combination with HMG CoA reductase inhibitors for treating cancer [P] . CZ9904486A3 . 2000-04-12

  机译： 法尼基转移酶抑制剂与HMG CoA还原酶抑制剂联合治疗癌症

• 4. Farnesyltransferase inhibitors in combination with HMG CoA reductase inhibitors for cancer treatment [P] . 日本专利： JP2000513031A . 2000-10-03

  机译： 法呢基转移酶抑制剂与HMG CoA还原酶抑制剂联合用于癌症治疗

• 5. Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer. [P] . OA11551A . 2004-05-24

  机译： 蛋白法呢基转移酶和HMG COA还原酶抑制剂的组合及其在治疗癌症中的用途。

• 1. Docking study on 3,5-dihydroxy heptenoates as 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGR) inhibitors [C] . Huajun Luo, Junzhi Wang, Kun Zou, 2013 International conference on computational sciences and engineering . 2013
• 2. New therapeutics for cerebral malaria: An investigation into the effect of HMG-CoA reductase inhibitors and anti-apoptotic strategies in experimental cerebral malaria. [D] . Helmers, Andrew. 2008
• 3. In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against [O] . Hye Jee Hahn, Anjan Debnath 2020
• 4. Relative Induction of mRNA for HMG CoA Reductase and LDL Receptor by Five Different HMG-CoA Reductase Inhibitors in Cultured Human Cells [O] . Shigeru Morikawa, Michihisa Umetani, Shunji Nakagawa, 2000
• 5. Effects of HMG-COA Reductase Inhibitor Therapy on LDL Cholesterol Blood Levels inHyperlipidemia: A Longitudinal Retrospective Anlaysis Using a Department of Defense Integrated Database [R] . Lee-Ziegler, C. L. 1998

• 1. Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA.Hy 926 cells [J] . Ayokunle O.Ademosun ,Ganiyu Oboh ,Sabina Passamonti . 食品科学与人类健康（英文） . 2015,第2期
• 2. Aspects of Antithrombotic Effect of HMG-CoA Reductase Inhibitors [J] . 贺石林 . 血栓与止血学 . 2005,第001期
• 3. Adverse reactions of HMG—CoA reductase inhibitors as a consequence of drug—drug interaction [J] . IkedaT . 中国药理学与毒理学杂志 . 2002,第006期
• 4. Relation between Baseline Lipid Levels and Effectiveness of HMG-CoA Reductase Inhibitors in Patients with Hyperlipidemia [J] . 伍卫 ,周淑娴 ,韦育林 . 岭南心血管病杂志：英文版 . 2001,第1期
• 5. The Heat Shock Protein Story—From Taking mTORC1,2 and Heat Shock Protein Inhibitors as Therapeutic Measures for Treating Cancers to Development of Cancer Vaccines [J] . Peter Chin Wan Fung ,Regina Kit Chee Kong . 癌症治疗（英文） . 2017,第11期
• 6. 鳞翅目害虫HMG-CoA还原酶抑制剂作为选择性杀虫剂的发现和定量构效关系研究 [C] . Yan-wei Qiu ,仇彦崴 ,Yang-yang Zang . 2017年上海市化学化工学会农用化学专业委员会年会暨上海市肥料农药行业协会专题研讨会 . 2017
• 7. HMG-CoA还原酶抑制剂与牛血清白蛋白相互作用研究 [A] . 王琪 . 2016